Status:
UNKNOWN
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
Lead Sponsor:
Boston Children's Hospital
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Conditions:
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Up to 1 years
Brief Summary
The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants with lung disease around discharge from ...
Detailed Description
Premature infants with bronchopulmonary dysplasia (BPD) have complex care needs around discharge. BPD affects up to 40% of former preterm infants born at \<28 weeks gestation, with about 10,000 new ca...
Eligibility Criteria
Inclusion
- Preterm infants born \<32 weeks with at least mild BPD, defined as 28 days of respiratory support after birth.
- Efforts will be made to include a mix of infants with mild, moderate, and severe BPD, including infants discharged on oxygen.
Exclusion
- Discharge to a location other than home.
- Infants with other congenital disease (cardiac, genetic, neurological) thought to contribute significantly to their respiratory disease.
Key Trial Info
Start Date :
September 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05285345
Start Date
September 27 2023
End Date
November 1 2025
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02115